Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunophenotype distinctions of CEBPA mutation subtypes in acute myeloid leukemia.

International journal of laboratory hematology - 1 Oct 2023

Liu Qiaoxue, Qi Ling, Yang Miao, Zhang Xue, Li Fei, Wei Hui, Wang Jianxiang

Abstract excerpt

INTRODUCTION: Acute myeloid leukemia (AML) patients with CEBPA double mutation (CEBPAdm ) were associated with distinct immunophenotypes and prognosis. Recently, both International Consensus Classification (ICC) and World Health Organization (WHO) classifications incorporated BZIP single mutations (CEBPAsmBZIP ) into the favorable risk group. However, the immunophenotypes of CEBPAsmBZIP mutations have not been...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CCAAT-Enhancer-Binding Proteins
Share to HLA-DR Antigens

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leukemia, Myeloid, Acute

Share to Mutation

Share to Prognosis

Source

Identifiers

PMID: 37334560
DOI: 10.1111/ijlh.14124

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunophenotype distinctions of CEBPA mutation subtypes in acute myeloid leukemia.PMID 37334560Read ↗

Mutational spectrum of acute myeloid leukemia patients with double CEBPA mutations based on next-generation sequencing and its prognostic significanceSemantic proximity Read ↗

CEBPA-bZip mutations are associated with favorable prognosis in de novo AML: a report from the Children's Oncology Group.Semantic proximity Read ↗

Impact of different CEBPA mutations on therapeutic outcome in acute myeloid leukemia.Semantic proximity Read ↗

Characterization of CEBPA mutations in acute myeloid leukemia: most patients with CEBPA mutations have biallelic mutations and show a distinct immunophenotype of the leukemic cells.Semantic proximity Read ↗

CEBPA mutations in acute myeloid leukemia: implications in risk stratification and treatment.Semantic proximity Read ↗

CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome.Semantic proximity Read ↗

[Type of CEBPA mutations in acute myeloid leukemia and their effect on prognosis].Semantic proximity Read ↗

Laboratory evaluation and prognostication among adults and children with CEBPA-mutant acute myeloid leukemia.Semantic proximity Read ↗

Novel insights of acute myeloid leukemia with CEBPA deregulation: Heterogeneity dissection and re-stratification.Semantic proximity Read ↗

[Prognostic significance of CEBPA gene mutations in acute myeloid leukemia].Semantic proximity Read ↗

[Genetic Mutation Profile and Risk Stratification of Cytogenetically Normal Acute Myeloid Leukemia with CEBPA-bZIP Mutations Based on Multi-Gene Sequencing].Semantic proximity Read ↗

Prognostic impact of CEBPA mutational subgroups in adult AML.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.